Eileen Liao

506 total citations
16 papers, 346 citations indexed

About

Eileen Liao is a scholar working on Molecular Biology, Hematology and Epidemiology. According to data from OpenAlex, Eileen Liao has authored 16 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Hematology and 4 papers in Epidemiology. Recurrent topics in Eileen Liao's work include Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (8 papers) and Ubiquitin and proteasome pathways (3 papers). Eileen Liao is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (8 papers) and Ubiquitin and proteasome pathways (3 papers). Eileen Liao collaborates with scholars based in United States, China and Australia. Eileen Liao's co-authors include Deborah Berg, Jesús G. Berdeja, Paul G. Richardson, Parameswaran Hari, S. Vincent Rajkumar, Shaji Kumar, Rubén Niesvizky, Mehdi Hamadani, Jonathan L. Kaufman and Jacob P. Laubach and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Eileen Liao

12 papers receiving 339 citations

Peers

Eileen Liao
Paul Schoen United Kingdom
María-Victoria Mateos Spain
Evžen Gregora Czechia
Leah Fink Switzerland
Kathleen Colson United States
M. Mietzel United States
Dixil Francis United States
Miguel Teodoro Hernández‐Garcia Spain
Xenofon Papanikolaou United States
Bonnie Jenkins United States
Paul Schoen United Kingdom
Eileen Liao
Citations per year, relative to Eileen Liao Eileen Liao (= 1×) peers Paul Schoen

Countries citing papers authored by Eileen Liao

Since Specialization
Citations

This map shows the geographic impact of Eileen Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Liao more than expected).

Fields of papers citing papers by Eileen Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Liao. The network helps show where Eileen Liao may publish in the future.

Co-authorship network of co-authors of Eileen Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Liao. A scholar is included among the top collaborators of Eileen Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Liao. Eileen Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sen, Monokesh K., et al.. (2025). Immunomodulatory effects of calorie restriction and its mimetics: A new potential therapeutic approach for autoimmune diseases. Pharmacological Reviews. 77(4). 100063–100063.
2.
3.
Huang, Xiaomei, et al.. (2024). FPR1 Antagonist (BOC-MLF) Inhibits Amniotic Epithelial-mesenchymal Transition. Current Medical Science. 44(1). 187–194.
4.
Sen, Monokesh K., et al.. (2023). Impact of a high fibre diet on immune cells and the multiple sclerosis animal model. The Journal of Immunology. 210(Supplement_1). 66.11–66.11. 1 indexed citations
5.
Huang, Xiaomei, Fan Feng, Eileen Liao, et al.. (2022). Combined Application of Exosomes and FPR2 Agonist LXA4 in Controlling Fetal Membrane Inflammation and Promoting Fetal Membrane Tissue Repair. Reproductive Sciences. 30(6). 1979–1993. 1 indexed citations
6.
Liao, Eileen, Laura Ghezzi, & Laura Piccio. (2022). Dietary restriction in multiple sclerosis: evidence from preclinical and clinical studies. SHILAP Revista de lepidopterología.
7.
MacLaren, Robert E., Byron L. Lam, Andrew Lotery, et al.. (2021). Visual function improvements with BIIB112 (NSR-RPGR) in X-linked retinitis pigmentosa: XIRIUS (dose-expansion) and XOLARIS (natural disease progression) studies. 62(8). 1479–1479. 1 indexed citations
8.
Kumar, Shaji, Jesús G. Berdeja, Rubén Niesvizky, et al.. (2019). Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance. Leukemia. 33(7). 1736–1746. 38 indexed citations
9.
Liao, Eileen, et al.. (2018). Resveratrol regulates the silent information regulator 1–nuclear factor‐κB signaling pathway in intrahepatic cholestasis of pregnancy. Hepatology Research. 48(12). 1031–1044. 13 indexed citations
10.
Richardson, Paul G., Craig C. Hofmeister, Cara A. Rosenbaum, et al.. (2018). Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma. British Journal of Haematology. 182(2). 231–244. 27 indexed citations
11.
12.
Richardson, Paul G., Craig C. Hofmeister, Cara A. Rosenbaum, et al.. (2017). Twice-weekly Ixazomib plus Lenalidomide-dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-term Follow-up Data for Patients Not Undergoing Stem Cell Transplantation (SCT). Clinical Lymphoma Myeloma & Leukemia. 17. S337–S337. 1 indexed citations
13.
Palumbo, Antonio, Gareth J. Morgan, S. Vincent Rajkumar, et al.. (2016). Two phase 3 studies of the oral proteasome inhibitor (PI) ixazomib for multiple myeloma (MM) in the maintenance setting: TOURMALINE-MM3, and -MM4.. Journal of Clinical Oncology. 34(15_suppl). TPS8068–TPS8068. 7 indexed citations
14.
15.
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Schoen Breakdown of academic impact, for papers by María-Victoria Mateos Breakdown of academic impact, for papers by Evžen Gregora Breakdown of academic impact, for papers by Leah Fink Breakdown of academic impact, for papers by Kathleen Colson Breakdown of academic impact, for papers by M. Mietzel Breakdown of academic impact, for papers by Dixil Francis Breakdown of academic impact, for papers by Miguel Teodoro Hernández‐Garcia Breakdown of academic impact, for papers by Xenofon Papanikolaou Breakdown of academic impact, for papers by Bonnie Jenkins
Rankless by CCL
2026